1. Home
  2. WLY vs BCRX Comparison

WLY vs BCRX Comparison

Compare WLY & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Wiley & Sons Inc.

WLY

John Wiley & Sons Inc.

HOLD

Current Price

$38.91

Market Cap

1.9B

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$9.46

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLY
BCRX
Founded
1807
1986
Country
United States
United States
Employees
5200
N/A
Industry
Books
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
WLY
BCRX
Price
$38.91
$9.46
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$20.82
AVG Volume (30 Days)
533.7K
5.9M
Earning Date
03-05-2026
05-04-2026
Dividend Yield
3.73%
N/A
EPS Growth
N/A
381.40
EPS
N/A
1.21
Revenue
N/A
$25,186,000.00
Revenue This Year
$1.04
N/A
Revenue Next Year
$2.36
$12.55
P/E Ratio
$15.84
$7.87
Revenue Growth
N/A
N/A
52 Week Low
$28.38
$6.00
52 Week High
$45.60
$11.31

Technical Indicators

Market Signals
Indicator
WLY
BCRX
Relative Strength Index (RSI) 73.08 62.53
Support Level $36.11 $7.85
Resistance Level $40.72 $10.32
Average True Range (ATR) 0.95 0.61
MACD -0.00 -0.05
Stochastic Oscillator 87.05 60.60

Price Performance

Historical Comparison
WLY
BCRX

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: